SOLTF
Price
$5.91
Change
+$0.41 (+7.45%)
Updated
May 29 closing price
Capitalization
567.44M
SPHDF
Price
$14.75
Change
-$1.15 (-7.23%)
Updated
May 28 closing price
Capitalization
204.08M
Interact to see
Advertisement

SOLTF vs SPHDF

Header iconSOLTF vs SPHDF Comparison
Open Charts SOLTF vs SPHDFBanner chart's image
Nxera Pharma
Price$5.91
Change+$0.41 (+7.45%)
Volume$1.11K
Capitalization567.44M
Santhera Pharmaceuticals Holdings
Price$14.75
Change-$1.15 (-7.23%)
Volume$285
Capitalization204.08M
SOLTF vs SPHDF Comparison Chart
Loading...
View a ticker or compare two or three
VS
SOLTF vs. SPHDF commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOLTF is a Hold and SPHDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (SOLTF: $5.91 vs. SPHDF: $14.75)
Brand notoriety: SOLTF and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SOLTF: 255% vs. SPHDF: 189%
Market capitalization -- SOLTF: $567.44M vs. SPHDF: $204.08M
SOLTF [@Biotechnology] is valued at $567.44M. SPHDF’s [@Biotechnology] market capitalization is $204.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SOLTF’s FA Score shows that 0 FA rating(s) are green whileSPHDF’s FA Score has 1 green FA rating(s).

  • SOLTF’s FA Score: 0 green, 5 red.
  • SPHDF’s FA Score: 1 green, 4 red.
According to our system of comparison, SPHDF is a better buy in the long-term than SOLTF.

Price Growth

SOLTF (@Biotechnology) experienced а 0.00% price change this week, while SPHDF (@Biotechnology) price change was -15.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.16%. For the same industry, the average monthly price growth was +3.07%, and the average quarterly price growth was -0.47%.

Industries' Descriptions

@Biotechnology (+6.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
SOLTF($567M) has a higher market cap than SPHDF($204M). SPHDF YTD gains are higher at: 56.582 vs. SOLTF (-4.019).
SOLTFSPHDFSOLTF / SPHDF
Capitalization567M204M278%
EBITDA-3.81BN/A-
Gain YTD-4.01956.582-7%
P/E RatioN/A2.53-
Revenue23.3BN/A-
Total Cash51BN/A-
Total Debt71.1BN/A-
FUNDAMENTALS RATINGS
SOLTF vs SPHDF: Fundamental Ratings
SOLTF
SPHDF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
7942
P/E GROWTH RATING
1..100
10012
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPHDF's Valuation (62) in the null industry is in the same range as SOLTF (85). This means that SPHDF’s stock grew similarly to SOLTF’s over the last 12 months.

SPHDF's Profit vs Risk Rating (100) in the null industry is in the same range as SOLTF (100). This means that SPHDF’s stock grew similarly to SOLTF’s over the last 12 months.

SOLTF's SMR Rating (91) in the null industry is in the same range as SPHDF (100). This means that SOLTF’s stock grew similarly to SPHDF’s over the last 12 months.

SPHDF's Price Growth Rating (42) in the null industry is somewhat better than the same rating for SOLTF (79). This means that SPHDF’s stock grew somewhat faster than SOLTF’s over the last 12 months.

SPHDF's P/E Growth Rating (12) in the null industry is significantly better than the same rating for SOLTF (100). This means that SPHDF’s stock grew significantly faster than SOLTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GGR0.25N/A
+0.37%
Gogoro
ABBV186.110.49
+0.26%
ABBVIE
VERU0.51N/A
-0.20%
Veru
DNN1.59-0.01
-0.62%
Denison Mines Corp
WF41.69-0.47
-1.11%
Woori Financial Group

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with TRML. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
TRML - SPHDF
78%
Closely correlated
+1.03%
COGT - SPHDF
63%
Loosely correlated
-1.27%
MEOBF - SPHDF
50%
Loosely correlated
N/A
KROS - SPHDF
38%
Loosely correlated
+0.93%
CYTOF - SPHDF
35%
Loosely correlated
+11.62%
More